Commission may not rely solely on comparative effectiveness research
The Health Evidence Review Commission, in ranking health services or developing guidelines under ORS 414.690 (Prioritized list of health services) or in assessing medical technologies under ORS 414.698 (Comparative effectiveness of medical technologies), and the Pharmacy and Therapeutics Committee, in considering a recommendation for a drug to be included on any preferred drug list or on the Practitioner-Managed Prescription Drug Plan, may not rely solely on the results of comparative effectiveness research. [2011 c.720 §26a]
Note: See note under 414.695 (Medical technology assessment).
3 OregonLaws.org assembles these lists by analyzing references between Sections. Each listed item refers back to the current Section in its own text. The result reveals relationships in the code that may not have otherwise been apparent.